Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients
NCT06443905 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 21600
Last updated 2024-06-05
Summary
The purpose of this study is to explore the efficacy, safety and cost-effectiveness of Xueshuantong (lyophilized) for the prevention of venous thromboembolism (VTE) in patients at risk of bleeding.
Conditions
- Venous Thromboembolism (VTE)
- Thromboembolism
Sponsors & Collaborators
-
Guangxi Wuzhou Pharmaceutical (GROUP) Co., Ltd.
collaborator UNKNOWN -
China-Japan Friendship Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-06-30
- Completion
- 2024-12-30
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
NCT06947707 ·Status: RECRUITING
-
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
NCT00911157 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis
NCT03217448 ·Status: UNKNOWN ·Phase: PHASE3
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
NCT07083609 ·Status: RECRUITING
-
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
NCT06904911 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
NCT06963320 ·Status: RECRUITING ·Phase: PHASE2
-
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
NCT00408239 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge
NCT00604370 ·Status: COMPLETED
-
Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.
NCT01958203 ·Status: COMPLETED
-
Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)
NCT02558465 ·Status: COMPLETED
-
A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database
NCT04923139 ·Status: COMPLETED
-
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing
NCT03330457 ·Status: TERMINATED ·Phase: PHASE2
-
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
NCT04128254 ·Status: UNKNOWN ·Phase: PHASE4
-
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
NCT02943993 ·Status: COMPLETED
-
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
NCT00799968 ·Status: COMPLETED ·Phase: PHASE4
-
Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism
NCT05382481 ·Status: UNKNOWN ·Phase: NA
-
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
NCT00793234 ·Status: COMPLETED ·Phase: PHASE2
-
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
NCT01028950 ·Status: COMPLETED ·Phase: PHASE3
-
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT05752461 ·Status: COMPLETED ·Phase: PHASE2
-
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
NCT01516840 ·Status: COMPLETED ·Phase: PHASE3
-
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
NCT00796692 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
NCT00246025 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
NCT02064439 ·Status: COMPLETED ·Phase: PHASE3
-
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2